We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

India’s Patent Laws Fall Short, Report Claims

Law360 (January 19, 2007, 12:00 AM EST) -- In a move that could spur changes to India’s intellectual property laws, an independent panel has called into question a key section of the country’s Patent Act, saying it is not fully in line with international standards.

The panel, headed by Dr. Ragunath Anand Mashelkar, Director-General of India’s Council of Scientific and Industrial Research, was tasked with determining whether limiting patent grants for pharmaceutical substances to new chemical entities (NCEs) is compatible with India’s obligations under Trade Related Aspects of Intellectual Property Rights (TRIPS).

Intellectual property...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.